ADRB2 and early-onset autosomal dominant Alzheimer disease: Consistent with our results, dysregulation of astrocytic β2-AR/cAMP signalling has been suspected to contribute to the pathology of a number of other neurologic disorders, including multiple sclerosis, Alzheimer’s disease, human immunodeficiency virus encephalitis, and others74.